Rhea BioVentures is a European specialist life sciences venture capital fund investing in cutting-edge innovation that shape the future of healthcare.
We back exceptional entrepreneurs developing breakthrough therapies, as well as the technologies, tools and services that improve how medicines are discovered, developed, manufactured and delivered.
We invest from seed through early growth stages across Europe and the US, with a particular interest in companies connected to the rapidly evolving Greek life sciences ecosystem.
Our approach is grounded in a simple conviction: transformative life sciences companies are built through scientific excellence, strategic execution and market alignment from day one.
Beyond capital, we bring an international network, industry relationships and decades of venture capital, company-building and board experience to help ambitious teams reach key scientific, commercial and financing milestones.
Investing Before the Future Becomes Obvious.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded
Investors
0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
What industry is Rhea BioVentures in?
Rhea BioVentures operates in Venture Capital and Private Equity Principals. Find similar Venture Capital and Private Equity Principals investors on gritt.io.
Where is Rhea BioVentures based?
Rhea BioVentures is headquartered in Athens, Greece.
Find investors for your startup like Rhea BioVentures
Gritt sends AI-personalised outreach to each investor — from your Gmail
